Table 3 Outcome variables
Placebo | Probiotic | Estimated Probiotic Effect* | |||||
|---|---|---|---|---|---|---|---|
Baseline | Final | % change | Baseline | Final | % change | Change in scale (95% CI). A positive value indicates a worsening in condition. | |
Intention to treat (n = 69 & n = 65) | |||||||
Global wellbeing (0–10 scale) | 3.2 (2.0) | 2.9 (2.3) | 9.4% | 4.1 (2.5) | 3.7 (3.0) | 9.8% | 0.16 (-0.61 to 0.93) |
Bowel symptoms | |||||||
Diarrhoea (0 – 10 scale) | 1.9 (2.7) | 1.0 (1.7) | 47% | 1.8 (2.6) | 1.4 (2.3) | 22% | 0.24 (-0.36 to 0.83) |
Stomach pain (0–10 scale) | 2.1 (2.6) | 1.2 (1.6) | 42% | 2.0 (2.7) | 1.4 (2.2) | 30% | 0.17 (-0.42 to 0.76) |
Blood in stools (0–10 scale) | 0.6 (1.8) | 0.5 (1.6) | 17% | 0.6 (1.6) | 0.4 (1.1) | 33% | -0.14 (-0.55 to 0.27) |
Arthritis severity | |||||||
Disease activity (0–10 scale) | 3.5 (1.9) | 2.9 (2.2) | 17% | 4.1 (2.2) | 3.6 (2.6) | 12% | 0.20 (-0.47 to 0.86) |
Function (0–10 scale) | 3.1 (2.4) | 2.8 (2.6) | 9.7% | 4.2 (2.9) | 4.0 (3.2) | 5% | -0.04 (-0.50 to 0.43) |